Related Experiment Videos
[Serum soluble interleukin-2 receptor levels in uveitis]
1Zhongshan Ophthalmic Center, Sun Yat-sen University of Medical Sciences, Guangzhou 510060, China.
Yan Ke Xue Bao = Eye Science
|February 13, 2003
Summary
Serum soluble interleukin-2 receptor (sIL-2R) levels are higher in active uveitis patients compared to controls. These levels decrease with therapy, indicating a correlation with uveitis activity.
Area of Science:
- Immunology
- Ophthalmology
Context:
- Uveitis is a group of intraocular inflammatory conditions.
- Accurate biomarkers for disease activity are crucial for effective management.
Purpose:
- To determine the relationship between serum soluble interleukin-2 receptor (sIL-2R) levels and the activity of uveitis.
Summary:
- Serum sIL-2R levels were significantly elevated in patients with active uveitis compared to healthy controls.
- No significant differences in sIL-2R levels were observed among different types of uveitis (anterior, intermediate, Behcet disease, Vogt-Koyanagi-Harada syndrome).
- Therapeutic intervention led to a notable decrease in serum sIL-2R levels.
Impact:
- Serum sIL-2R may serve as a potential biomarker for monitoring uveitis activity.
- Findings support the role of T-cell activation in the pathogenesis of uveitis.